The extensive scope and intensive coverage of new developments in cancer therapeutics at this annual educational activity provide cancer care providers with the opportunity to learn about the new agents, new modalities, clinical trials and emerging developments that will result in continuing progress towards the control and cure of cancer.
At the conclusion of the program participants should be able to:
Oncologists, Hematologists, Breast Cancer Oncologists, Gynecological Oncologists, Surgical Oncologists, Pediatric Oncologists, Radiotherapists, Immunologists, Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers, Pharmacists
The Icahn School of Medicine at Mount Sinai is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 24.25 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Verification of Attendance
Will be provided to all professionals.
Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers
CME hours for the Wednesday through Friday sessions, November 6-8 may be submitted to credentialing organizations for acceptance of conversion to CE.
The NYS Council of Health-system Pharmacists is accredited by the New York State Council of Pharmacy Education as a provider of continuing pharmacy education. This activity has been approved for a total of 29.25 contact hours. Statements of continuing pharmacy education are available at healthsystems.org upon the conclusion of the program. Participants must verify attendance at the meeting by entering the program CE code. Attendees have sixty days (60) to evaluate the program and obtain their statements of credit.
It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency and scientific rigor in all CME sponsored educational activities. All faculty participating in the planning or implementation of a supported activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict-of-interest that may arise from the situation. Presenters must also make a meaningful disclosure to the audience in their discussions of unlabeled or unapproved drugs or devices.
Conference Management Director: Jaclyn Silverman email: Jaclyn.firstname.lastname@example.org | Phone 212 866 2813
A Professional Education Program of The Chemotherapy Foundation
Conference Management Director
The Mount Sinai Medical Center
One Gustave L. Levy Place
New York , NY 10029
Tel: (212) 866-2813
Fax: (646) 215-7589
Tel: (212) 731-7950
Tel: (212) 731-7950